1-13 of 13
Amber Koehler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N. Noble, Côme Bommier, Carla Casulo, Carrie Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle Hildebrandt, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Susan L. Slager, Andrew L. Feldman, David L Jaye, Jon Tilburt, J. C. C. Villasboas, Ajay Major, Priyanka A Pophali, Talal Hilal, Yucai Wang, Timothy G. Call, Amber Koehler, Javier L. Munoz, Gita Thanarajasingam, Paul J Hampel, Sameer A. Parikh, Loretta J. Nastoupil, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M Ansell, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 3761.
https://doi.org/10.1182/blood-2023-188382
Published: 2023
Journal Articles

Outcomes of Patients with Small Lymphocytic Lymphoma (SLL) Receiving First Line Treatment

Samuel Kosydar, Kari G. Rabe, Yucai Wang, Saad S. Kenderian, Wei Ding, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Talal Hilal, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Sameer A. Parikh, Paul J Hampel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3284.
https://doi.org/10.1182/blood-2023-181866
Published: 2023
Journal Articles

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Paul J. Hampel, Kari G. Rabe, Yucai Wang, Steven R Hwang, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Wei Ding, Sameer A. Parikh
Journal: Blood
Blood (2023) 142 (Supplement 1): 3271.
https://doi.org/10.1182/blood-2023-185076
Published: 2023
Journal Articles

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Paul J. Hampel, Kari G. Rabe, Yucai Wang, Saad S. Kenderian, Wei Ding, Eli Muchtar, Jose F. Leis, Amber Koehler, Mazie Tsang, Ricardo Parrondo, Rachel Bubik, Susan Marie Schwager, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Min Shi, Daniel L. Van Dyke, Timothy G. Call, Neil E. Kay, Sameer A. Parikh
Journal: Blood
Blood (2023) 142 (Supplement 1): 3276.
https://doi.org/10.1182/blood-2023-183007
Published: 2023
Journal Articles

Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional Prospective Cohort Study

Amber Koehler, Brie N. Noble, Timothy G. Call, Sameer A. Parikh, Tait D. Shanafelt, Mazie Tsang, Côme Bommier, Kari G. Rabe, Christopher Strouse, Carrie Thompson, Paul J. Hampel, Kathleen Yost, Melissa C. Larson, Susan L. Slager, Brian K. Link, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 498.
https://doi.org/10.1182/blood-2023-187268
Published: 2023
Journal Articles

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations

Steven R Hwang, Yucai Wang, Kari G Rabe, Rong He, Saad S. Kenderian, Eli Muchtar, Paul J. Hampel, Neil E. Kay, Timothy G. Call, Amber Koehler, Amy L Behnken, Jose F. Leis, Esteban Braggio, Min Shi, David S. Viswanatha, Daniel L. Van Dyke, Susan L. Slager, Sameer A. Parikh, Wei Ding
Journal: Blood
Blood (2022) 140 (Supplement 1): 12390–12392.
https://doi.org/10.1182/blood-2022-165508
Published: 2022
Journal Articles

Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Combination of Ibrutinib (I) and Venetoclax (V; I+V) after Progression on I Alone (V-naïve) or after Progression on Sequential I and V (Double-Refractory)

Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber Koehler, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Journal: Blood
Blood (2021) 138 (Supplement 1): 1560.
https://doi.org/10.1182/blood-2021-151668
Published: 2021
Journal Articles

Immunogenicity of a Recombinant Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia

Eli Muchtar, MD, Amber Koehler, PA-C, Michael J Johnson, Kari G Rabe, Wei Ding, MD PhD, Timothy G. Call, MD, Jose F. Leis, MD PhD, Saad S. Kenderian, MB, ChB, Suzanne R. Hayman, MD, Yucai Wang, MDPhD, Paul J. Hampel, MD, Mathew Holets, Heather C Darby, Susan L. Slager, PhD, Neil E. Kay, MD, Jennifer A Whitaker, Myron Levin, Richard Kennedy, Adriana Weinberg, Sameer A. Parikh, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-140338
Published: 2020
Journal Articles

Use of Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation (AF) in Patients with Chronic Lymphocytic Leukemia (CLL)

Georgios Christopoulos, MD, Zachi I. Attia, PhD, Peter A. Noseworthy, MD, Timothy G. Call, MD, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Eli Muchtar, MD, Saad S. Kenderian, MB, ChB, Yucai Wang, MDPhD, Amber Koehler, PA-C, Neil E. Kay, MD, Prashant Kapoor, MD, Paul A. Friedman, MD, Joerg Herrmann, MD, Sameer A. Parikh, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–51.
https://doi.org/10.1182/blood-2020-142645
Published: 2020
Journal Articles

BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression

Paul J. Hampel, MD, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Wei Ding, MD PhD, Eli Muchtar, MD, Saad S. Kenderian, MD, Yucai Wang, MD PhD, Amber Koehler, PA-C, MS, Amie Fonder, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3050.
https://doi.org/10.1182/blood-2019-125411
Published: 2019
Journal Articles

The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis

William J Archibald, MDCPA, Timothy G. Call, MD, Sara J. Achenbach, Kari G Rabe, Curtis A. Hanson, MD, Wei Ding, MD PhD, Amber Koehler, PA-C, MS, Eli Muchtar, MD, Suzanne R. Hayman, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Yucai Wang, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Daniel L. Van Dyke, PhD, Susan M. Schwager, Susan L. Slager, PhD, Neil E. Kay, MD, Sameer A. Parikh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3037.
https://doi.org/10.1182/blood-2019-131154
Published: 2019
Journal Articles

A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Sameer A. Parikh, MD, Eli Muchtar, MD, Betsy Laplant, MS, Wei Ding, MD PhD, Sikander Ailawadhi, MD, Amber Koehler, PA-C, MS, Timothy G. Call, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Asher A. Chanan-Khan, MD, Adam Pettinger, Thomas E. Witzig, MD, Carrie A. Thompson, MD, Jose C Villasboas, Jessica M Sholes, Curtis A. Hanson, MD, Esteban Braggio, PhD, Kay L. Medina, PhD, Susan L. Slager, PhD, Neil E. Kay, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4306.
https://doi.org/10.1182/blood-2019-123824
Published: 2019
Journal Articles

A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalidomide in Patients with Relapsed/Refractory CLL, DLBCL or Other B-Cell Lymphomas

Anthony R. Mato, MDMSCE, Stephen J Schuster, MD, Francine M. Foss, MD, Iris Isufi, MD, Wei Ding, MD PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Han W. Tun, MD, Muhamad Alhaj Moustafa, MD, Kaitlin Kennard, RN, BSN, Cara M King, MPH, Amber Koehler, PA-C, MS, Casey Aitken, Wei He, PhD, Albert Kearney, PhD, Min Gui, PhD, Barry Douglas Anderson, MD PhD, Allison C. Rosenthal, DO, Lindsey E. Roeker, MD, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 810.
https://doi.org/10.1182/blood-2019-126192
Published: 2019